| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 1743 | 2013 |
| Efficacy and safety of alirocumab in reducing lipids and cardiovascular events JG Robinson, M Farnier, M Krempf, J Bergeron, G Luc, M Averna, ... New England Journal of Medicine 372 (16), 1489-1499, 2015 | 1680 | 2015 |
| Thromboxane biosynthesis and platelet function in type II diabetes mellitus G Davě, I Catalano, M Averna, A Notarbartolo, A Strano, G Ciabattoni, ... New England Journal of Medicine 322 (25), 1769-1774, 1990 | 757 | 1990 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 595 | 2014 |
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 572 | 2013 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 427 | 2015 |
| A novel component of the metabolic syndrome: the oxidative stress E Hopps, D Noto, G Caimi, MR Averna Nutrition, Metabolism and Cardiovascular Diseases 20 (1), 72-77, 2010 | 353 | 2010 |
| Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia A Notarbartolo, G Davı̀, M Averna, CM Barbagallo, A Ganci, ... Arteriosclerosis, thrombosis, and vascular biology 15 (2), 247-251, 1995 | 351 | 1995 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 344 | 2014 |
| A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke F Cipollone, E Toniato, S Martinotti, M Fazia, A Iezzi, C Cuccurullo, B Pini, ... Jama 291 (18), 2221-2228, 2004 | 314 | 2004 |
| Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children A Carroccio, G Iacono, M Cottone, L Di Prima, F Cartabellotta, F Cavataio, ... Clinical chemistry 49 (6), 861-867, 2003 | 273 | 2003 |
| Increased thromboxane biosynthesis in type IIa hypercholesterolemia. G Davi, M Averna, I Catalano, C Barbagallo, A Ganci, A Notarbartolo, ... Circulation 85 (5), 1792-1798, 1992 | 230 | 1992 |
| Gastrointestinal symptoms in infancy: a population-based prospective study G Iacono, R Merolla, D D’Amico, E Bonci, F Cavataio, L Di Prima, ... Digestive and liver disease 37 (6), 432-438, 2005 | 218 | 2005 |
| Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype S Bertolini, A Cantafora, M Averna, C Cortese, C Motti, S Martini, G Pes, ... Arteriosclerosis, thrombosis, and vascular biology 20 (9), e41-e52, 2000 | 164 | 2000 |
| Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study A Carroccio, G Vitale, L Di Prima, N Chifari, S Napoli, C La Russa, ... Clinical chemistry 48 (9), 1546-1550, 2002 | 163 | 2002 |
| Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: the ODYSSEY OPTIONS II … M Farnier, P Jones, R Severance, M Averna, E Steinhagen-Thiessen, ... Atherosclerosis 244, 138-146, 2016 | 158 | 2016 |
| Fatty liver in familial hypobetalipoproteinemia triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis G Schonfeld, BW Patterson, DA Yablonskiy, TSK Tanoli, M Averna, ... Journal of lipid research 44 (3), 470-478, 2003 | 151 | 2003 |
| European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... Eur Heart J 35 (32), 2146-2157, 2014 | 149 | 2014 |
| Molecular diagnosis of hypobetalipoproteinemia: an ENID review P Tarugi, M Averna, E Di Leo, AB Cefalů, D Noto, L Magnolo, L Cattin, ... Atherosclerosis 195 (2), e19-e27, 2007 | 149 | 2007 |
| Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor α-mediated pathway RAK Srivastava, N Srivastava, M Averna, RC Lin, KS Korach, DB Lubahn, ... Journal of Biological Chemistry 272 (52), 33360-33366, 1997 | 143 | 1997 |
